Backs FY24 revenue view up 4.5%-5.5%, consensus $7.75B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on ZBH: Zimmer Biomet Announces First Quarter 2024 Financial Results Zimmer Biomet becomes official medical device partner of U.S. pickleball Zimmer Biomet price target raised to $140 from $134 at Citi Zimmer Biomet price target raised to $129 from $120 at Roth MKM Disclaimer & DisclosureReport an Issue
